Santa Fe Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-4,362
Closed -$359K 546
2015
Q3
$359K Buy
+4,362
New +$388K 0.05% 388
2015
Q1
Sell
-18,177
Closed -$1.51M 564
2014
Q4
$1.51M Sell
18,177
-21,329
-54% -$1.77M 0.19% 228
2014
Q3
$3.33M Buy
39,506
+30,744
+351% +$2.49M 0.52% 1
2014
Q2
$711K Sell
8,762
-39,057
-82% -$3.07M 0.11% 323
2014
Q1
$3.64M Buy
47,819
+13,826
+41% +$1.01M 0.52% 1
2013
Q4
$2.45M Sell
33,993
-4,185
-11% -$291K 0.4% 82
2013
Q3
$2.63M Buy
38,178
+24,882
+187% +$1.65M 0.5% 36
2013
Q2
$842K Buy
+13,296
New +$865K 0.17% 225

Other funds holding NVS

Santa Fe Partners's NVS Position: Q4 2015 in Review

Santa Fe Partners sold out of Novartis (NVS) in Q4 2015, closing a stake of 4,362 shares — an estimated $359K sold.

Santa Fe Partners first reported a position in NVS in Q2 2013 and held it in 8 quarters. The position peaked at $3.64M in Q1 2014. 926 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

  • Santa Fe Partners reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
  • Santa Fe Partners sold 4,362 Novartis shares in Q4 2015, an estimated $359K.
  • Santa Fe Partners first reported a position in Novartis in Q2 2013 and held it in 8 quarters.
  • Santa Fe Partners's Novartis position peaked at $3.64M in Q1 2014.
  • 926 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Santa Fe Partners's 13F filing for Q4 2015, filed 12 Feb 2016.